GL1X · GenesisL1 explorer

Research workbench

Truncation and optimisation of peptide inhibitors of CDK2, cyclin a through structure guided design

Analyse Truncation and optimisation of peptide inhibitors of CDK2, cyclin a through… in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.

PDB
2WFY
Type
protein
Length
1,116 residues
Chains
6
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Cell division protein kinase 2; Cyclin-A2; Arg-arg-B3L-phe
EC
2.7.1.37
UniProt
P24941, P20248
Ligands
ACE, NH2
Pockets
14 · best druggability 0.81

Structure

x-ray diffraction · 5 distinct chains · 49% helix, 10% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
ACell division protein kinase 2 (EC 2.7.1.37)protein29534% helix, 18% strandP24941
BCyclin-A2protein25766% helix, 0% strandP20248
CCell division protein kinase 2 (EC 2.7.1.37)protein29633% helix, 18% strandP24941
DCyclin-A2protein26067% helix, 0% strandP20248
E, FArg-arg-B3L-pheprotein40% helix, 0% strand—

Ligands and binding sites

  • ACE · Acetyl group · ligand · 2 copies · chains B, E, D, F
  • NH2 · Amino group · ion · 2 copies · chains B, E, D, F

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

14 pockets found on a 1 Å grid, 7 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
11450.810.9823empty
21480.810.9726empty
310080.780.80121empty
45870.670.7756empty
54120.640.7845empty

Interfaces

7 interfaces between chains.

  • C–D · 1743 Ų buried · 24 hydrogen bonds · protein-protein
  • A–B · 1738 Ų buried · 18 hydrogen bonds · protein-protein
  • B–C · 494 Ų buried · 2 hydrogen bonds · protein-protein
  • A–D · 448 Ų buried · 2 hydrogen bonds · protein-protein
  • D–F · 410 Ų buried · 5 hydrogen bonds · protein-protein

Modifications

Observed in the structure: 2 covalent, 2 modified (covalent ligand, nonstandard).

Compared structures

  • 2WFY · Truncation and Optimisation of Peptide Inhibitors of CDK2, Cyclin A Through Structure… · the same entry in another collection · chain B against B, TM-score 1.00
  • P20248 · AlphaFold monomer V2.0 prediction for cyclin-A2 (P20248) · a predicted model of the same protein · chain B against A, TM-score 0.99
  • P24941 · AlphaFold monomer V2.0 prediction for cyclin-dependent kinase 2 (P24941) · a predicted model of the same protein · chain C against A, TM-score 0.91

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.